TSX News -
Trillium Therapeutics Reports Third Quarter 2017 Financial and Operating Results
TORONTO, ONTARIO–(Marketwired – Nov. 10, 2017) – Trillium Therapeutics Inc. (NASDAQ:TRIL)(TSX:TRIL), a clinical stage immuno-oncology company developing innovative therapies for [...]